Hepatology · 1998 · 25 citations · 51 references
MedicineImmunologyOncologyCancer ImmunologyMetastasisTumor ImmunologyCancer ImmunotherapyInterferon-based TherapyLiver CancerLiver MetastasisMetastatic Disease TreatmentTumor Microenvironment ModulationExperimental Metastasis AssaysLiver Metastases TreatmentLiver Tumor TherapyMetastatic Growth KineticsMetastatic Liver Disease TreatmentTherapy-induced Growth InhibitionTumor Metastasis Biology
The purpose of this study was to investigate the combined antitumor effect of aminated beta-1,3-D-glucan (AG) and interferon-gamma (IFN-gamma) in an experimental liver metastasis model. Liver metastases were established by inoculation of C-26 colon carcinoma cells into the superior mesenteric vein of syngeneic mice. Treatment of mice started 24 hours after inoculation of tumor cells by daily intravenous injections of either AG, IFN-gamma, or a combination of both for a duration of 6 days. The resultant liver metastases were then quantified after an additional period of 11 days. Combination of IFN-gamma and AG inhibited the growth of liver metastases almost entirely. IFN-gamma was also very efficient, while AG alone did not exert any significant antitumor effect. These results, along with histological studies from mice receiving AG and IFN-gamma, indicated that activation and recruitment of liver macrophages may be a part of the mechanism responsible for the inhibition of metastatic growth observed in this study.
51
Nitric oxide as a secretory product of mammalian cells
Carl Nathan · The FASEB Journal · 1992 · 4.4K citations
E. Silverberg, C. C. Boring, T. S. Squires · CA A Cancer Journal for Clinicians · 1990 · 816 citations · Full text
Medicine, Oncology, Oncology Nursing +15
D Liénard, Patricia Ewalenko, Jean-Baptiste Delmotte et al. · Journal of Clinical Oncology · 1992 · 723 citations
Pharmacy, Oncology, Pharmacotherapy +17